| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 421.17B | 421.67B | 370.68B | 417.62B | 462.82B | 302.38B |
| Gross Profit | 13.25B | 14.50B | 13.61B | 15.96B | 14.21B | 7.75B |
| EBITDA | 10.13B | 10.40B | 10.05B | 12.59B | 10.78B | 5.11B |
| Net Income | 5.32B | 5.59B | 2.10B | 4.91B | 6.38B | 3.45B |
Balance Sheet | ||||||
| Total Assets | 158.74B | 114.01B | 130.24B | 107.33B | 117.07B | 120.00B |
| Cash, Cash Equivalents and Short-Term Investments | 6.10B | 13.17B | 20.86B | 12.14B | 8.22B | 9.55B |
| Total Debt | 48.77B | 14.20B | 29.75B | 20.73B | 9.55B | 14.63B |
| Total Liabilities | 110.76B | 64.39B | 84.73B | 63.13B | 77.70B | 87.20B |
| Stockholders Equity | 47.98B | 49.62B | 45.51B | 43.21B | 38.59B | 32.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.20B | 4.41B | -5.17B | 5.75B | -11.59B |
| Operating Cash Flow | 0.00 | 9.21B | 4.42B | -4.96B | 5.90B | -11.58B |
| Investing Cash Flow | 0.00 | -21.00M | 494.00M | -263.00M | -183.00M | 401.00M |
| Financing Cash Flow | 0.00 | -16.85B | 2.90B | 8.58B | -7.60B | 10.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥90.07B | 6.87 | ― | 1.72% | 36.31% | 101.77% | |
70 Outperform | ¥69.15B | 15.74 | 5.37% | 3.41% | -12.80% | 4.26% | |
69 Neutral | ¥109.70B | 10.73 | ― | 0.93% | 28.52% | 43.16% | |
66 Neutral | ¥84.88B | 8.78 | ― | 2.41% | 16.05% | 3.58% | |
65 Neutral | ¥81.51B | 17.02 | ― | 1.85% | 3.60% | -17.45% | |
64 Neutral | ¥410.26B | 14.59 | ― | 2.87% | 8.99% | -43.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |